These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23279260)
1. The role of apolipoprotein A5 in obesity and the metabolic syndrome. Zheng XY; Zhao SP; Yan H Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260 [TBL] [Abstract][Full Text] [Related]
2. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. Su X; Kong Y; Peng DQ Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content. Zheng XY; Zhao SP; Yu BL; Wu CL; Liu L Biol Chem; 2012 Mar; 393(3):161-7. PubMed ID: 22718631 [TBL] [Abstract][Full Text] [Related]
4. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents. Zaki M; Amr K Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374 [TBL] [Abstract][Full Text] [Related]
7. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome. Niculescu LS; Vlădică M; Sima AV Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084 [TBL] [Abstract][Full Text] [Related]
8. Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease. Wu CL; Zhao SP; Yu BL Biol Rev Camb Philos Soc; 2015 May; 90(2):367-76. PubMed ID: 24834836 [TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219 [TBL] [Abstract][Full Text] [Related]
10. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102 [TBL] [Abstract][Full Text] [Related]
11. The role of apolipoprotein A5 in non-alcoholic fatty liver disease. Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of apolipoprotein A5. Tai ES; Ordovas JM Curr Opin Lipidol; 2008 Aug; 19(4):349-54. PubMed ID: 18607181 [TBL] [Abstract][Full Text] [Related]
14. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism. Forte TM; Ryan RO Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042 [TBL] [Abstract][Full Text] [Related]
16. New Insights into Apolipoprotein A5 and the Modulation of Human Adipose-derived Mesenchymal Stem Cells Adipogenesis. Su X; Weng S; Peng D Curr Mol Med; 2020; 20(2):144-156. PubMed ID: 31560287 [TBL] [Abstract][Full Text] [Related]
17. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598 [TBL] [Abstract][Full Text] [Related]
18. [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease]. Oliveira Sousa M; Alía P; Pintó X Med Clin (Barc); 2008 May; 130(20):787-93. PubMed ID: 18579034 [TBL] [Abstract][Full Text] [Related]
19. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Garelnabi M; Lor K; Jin J; Chai F; Santanam N Clin Biochem; 2013 Jan; 46(1-2):12-9. PubMed ID: 23000317 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]